Targeted therapy in Tel Aviv typically costs from $7,200 to $16,800. The final expense depends on the specific drug regimen, the clinical stage of the tumor, and the necessary genomic profiling. Patients save around 64% compared to the US, where this procedure costs $40,000 on average. Inclusions often cover hospital stays, multidisciplinary planning, and transfers to the clinic.
Bookimed Expert Insight: Tel Aviv hosts more Newsweek-ranked oncology departments than any other city in Israel. This concentration of expertise allows for highly specific protocols, such as KADCYLA therapy for breast cancer. Clinics like Sourasky Medical Center (Ichilov) serve as JCI-accredited hubs where patients access Oxford-trained specialists. These doctors often lead national genomic medicine initiatives, providing access to clinical trials not available elsewhere.
| Israel | Turkey | Austria | |
| Targeted therapy | from $9,500 | from $1,000 | from $12,000 |
| Lutetium-177 therapy | from $16,500 | from $10,000 | from $35,000 |
| Oncothermia | - | from $450 | - |
| Actinium-225 Therapy | - | from $22,955 | from $55,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Targeted therapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Targeted therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Targeted therapy journey.
Day 1: Arrival
Day 2: Pre-Operation Stage
Day 3: Targeted Therapy
Day 4: Post-Operation Stage
Week 1-2: Rehabilitation
Please note that each patient"s case is individual and can vary.
Dr. Raphael leads Israel's National Genomic Medicine Initiative and pioneers targeted therapy trials at Sourasky Medical Center.
Dr. Pelles Sharon is a respected oncologist with extensive experience in targeted therapy and other advanced cancer treatments at Sourasky Medical Center.
Professor Ofer Merimsky leads the Soft Tissue and Bone Oncology unit at Sourasky Medical Center – Israel's top sarcoma specialist.
Dr. Sarid has published 30+ articles on cancer therapy and leads clinical trials in targeted treatments at Sourasky Medical Center.
Written by Anna Shchur